These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel Helicobacter pylori therapeutic targets: the unusual suspects. Duckworth MJ; Okoli AS; Mendz GL Expert Rev Anti Infect Ther; 2009 Sep; 7(7):835-67. PubMed ID: 19735225 [TBL] [Abstract][Full Text] [Related]
3. An engineered riboswitch as a potential gene-regulatory platform for reducing antibacterial drug resistance. Feng X; Liu L; Duan X; Wang S Chem Commun (Camb); 2011 Jan; 47(1):173-5. PubMed ID: 20589309 [TBL] [Abstract][Full Text] [Related]
4. Fluoride mechanisms. ten Cate JM; van Loveren C Dent Clin North Am; 1999 Oct; 43(4):713-42, vii. PubMed ID: 10553252 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a 1,4-disubstituted 1,2,3-triazole binding to T box antiterminator RNA. Zhou S; Means JA; Acquaah-Harrison G; Bergmeier SC; Hines JV Bioorg Med Chem; 2012 Feb; 20(3):1298-302. PubMed ID: 22230198 [TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial properties of sanguinaria, stannous fluoride and zinc chloride on the growth and acid production of Streptococcus mutans (in vitro)]. Gómez S; Baum RH Odontol Chil; 1987 Dec; 35(2):89-94. PubMed ID: 3275255 [No Abstract] [Full Text] [Related]
7. The effect of acid and fluoride release on the antimicrobial properties of four glass ionomer cements. Fischman SA; Tinanoff N Pediatr Dent; 1994; 16(5):368-70. PubMed ID: 7831144 [No Abstract] [Full Text] [Related]
9. Current status of release of fluoride ions and other bioactive agents from dental materials: prospects for controlled release. Masuhara E; Kadoma Y; Fujisawa S Crit Rev Ther Drug Carrier Syst; 1985; 1(2):91-119. PubMed ID: 3913526 [TBL] [Abstract][Full Text] [Related]
11. [Use of antibiotics in the selection of microorganisms producing biologically active substances]. Zhukova RA; Lavrent'eva GI Antibiotiki; 1983 Jun; 28(6):462-71. PubMed ID: 6349523 [No Abstract] [Full Text] [Related]
13. Pulpal response to cavity treatment with microbicidal solution and silicate restorations in monkeys. Beargrie GS; Brännström M Dent J; 1977 May; 43(5):239-43. PubMed ID: 404169 [No Abstract] [Full Text] [Related]
14. Effects of different kinds of fluorides on enolase and ATPase activity of a fluoride-sensitive and fluoride-resistant Streptococcus mutans strain. van Loveren C; Hoogenkamp MA; Deng DM; ten Cate JM Caries Res; 2008; 42(6):429-34. PubMed ID: 18832829 [TBL] [Abstract][Full Text] [Related]
15. The sequence of pbp2b from penicillin-resistant Streptococcus pneumoniae in Thailand. Tribuddharat C; Polwichai P; Champreeda P; Srifuengfung S J Med Assoc Thai; 2010 Nov; 93 Suppl 5():S16-26. PubMed ID: 21294378 [TBL] [Abstract][Full Text] [Related]
16. Functional characterization of MexXY and OpmG in aminoglycoside efflux in Pseudomonas aeruginosa. Chuanchuen R; Wannaprasat W; Schweizer HP Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):115-22. PubMed ID: 18567450 [TBL] [Abstract][Full Text] [Related]
17. Antibiofilm activity of nanosized magnesium fluoride. Lellouche J; Kahana E; Elias S; Gedanken A; Banin E Biomaterials; 2009 Oct; 30(30):5969-78. PubMed ID: 19664818 [TBL] [Abstract][Full Text] [Related]
18. Fatty-acid profiles and expression of the fabM gene in a fluoride-resistant strain of Streptococcus mutans. Zhu L; Zhang Z; Liang J Arch Oral Biol; 2012 Jan; 57(1):10-4. PubMed ID: 21741617 [TBL] [Abstract][Full Text] [Related]
19. Production of avilamycin A is regulated by AviC1 and AviC2, two transcriptional activators. Rebets Y; Boll R; Horbal L; Fedorenko V; Bechthold A J Antibiot (Tokyo); 2009 Aug; 62(8):461-4. PubMed ID: 19609289 [No Abstract] [Full Text] [Related]
20. Activation of cryptic aminoglycoside resistance in Salmonella enterica. Koskiniemi S; Pränting M; Gullberg E; Näsvall J; Andersson DI Mol Microbiol; 2011 Jun; 80(6):1464-78. PubMed ID: 21507083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]